PharmacoEconomics & Outcomes News

, Volume 708, Issue 1, pp 7–7

Monitoring inactive hep B carriers worth it in China?

Clinical study


  1. Toy M, et al. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China. Hepatology 60: 46-55, No. 1, Jul 2014. Available from: URL: PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Personalised recommendations